Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012


#87524

140pages

GlobalData

$ 1000

In Stock

 

 

GlobalData's clinical trial report, Metastatic Breast Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Breast Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Breast Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Metastatic Breast Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

 

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

 

Scope

 

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

 

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

 

 

Table of Contents

 

 

Table of Contents 2
List of Tables 5
List of Figures 7
 

Introduction 8
Metastatic Breast Cancer 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Metastatic Breast Cancer 25
Subjects Recruited Over a Period of Time 33
Prominent Sponsors 34
Top Companies Participating in Metastatic Breast Cancer Therapeutics Clinical Trials 36
Prominent Drug Comparison 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
GlaxoSmithKline plc 39
Clinical Trial Overview of GlaxoSmithKline plc 39
Eli Lilly and Company 42
Clinical Trial Overview of Eli Lilly and Company 42
F. Hoffmann-La Roche Ltd. 44
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 44
Novartis AG 47
Clinical Trial Overview of Novartis AG 47
Bristol-Myers Squibb Company 49
Clinical Trial Overview of Bristol-Myers Squibb Company 49
Pfizer Inc. 51
Clinical Trial Overview of Pfizer Inc. 51
AstraZeneca PLC 53
Clinical Trial Overview of AstraZeneca PLC 53
Amgen Inc. 55
Clinical Trial Overview of Amgen Inc. 55
Celgene Corporation 56
Clinical Trial Overview of Celgene Corporation 56
Sanofi 57
Clinical Trial Overview of Sanofi 57
Genentech, Inc. 58
Clinical Trial Overview of Genentech, Inc. 58
Taiho Pharmaceutical Co., Ltd. 59
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 59
Intas Pharmaceuticals Ltd. 60
Clinical Trial Overview of Intas Pharmaceuticals Ltd. 60
Eisai Inc. 61
Clinical Trial Overview of Eisai Inc. 61
Boehringer Ingelheim GmbH 62
Clinical Trial Overview of Boehringer Ingelheim GmbH 62
US Oncology, Inc. 63
Clinical Trial Overview of US Oncology, Inc. 63
ARCAGY - GINECO 64
Clinical Trial Overview of ARCAGY - GINECO 64
Merck & Co., Inc. 65
Clinical Trial Overview of Merck & Co., Inc. 65
Johnson & Johnson 66
Clinical Trial Overview of Johnson & Johnson 66
Dr. Reddy's Laboratories Limited 67
Clinical Trial Overview of Dr. Reddy's Laboratories Limited 67
Clinical Trial Overview of Top Universities / Institutes / Hospitals 68
The University of Texas M. D. Anderson Cancer Center 68
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 68
Memorial Sloan Kettering Cancer Center 72
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 72
Dana-Farber Cancer Institute 74
Clinical Trial Overview of Dana-Farber Cancer Institute 74
Vanderbilt-Ingram Cancer Center 75
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 75
Sarah Cannon Research Institute 76
Clinical Trial Overview of Sarah Cannon Research Institute 76
University of Medicine and Dentistry New Jersey 77
Clinical Trial Overview of University of Medicine and Dentistry New Jersey 77
FUDAN University 78
Clinical Trial Overview of FUDAN University 78
Fred Hutchinson Cancer Research Center 79
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 79
Southeastern Medical Oncology Center 80
Clinical Trial Overview of Southeastern Medical Oncology Center 80
Stanford University 81
Clinical Trial Overview of Stanford University 81
Sidney Kimmel Comprehensive Cancer Center 82
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 82
Northwestern University 83
Clinical Trial Overview of Northwestern University 83
Mayo Clinic 84
Clinical Trial Overview of Mayo Clinic 84
European Organization for Research and Treatment of Cancer 85
Clinical Trial Overview of European Organization for Research and Treatment of Cancer 85
Southwest Oncology Group 86
Clinical Trial Overview of Southwest Oncology Group 86
Duke University 87
Clinical Trial Overview of Duke University 87
Washington University School of Medicine 88
Clinical Trial Overview of Washington University School of Medicine 88
Albert Einstein College of Medicine of Yeshiva University 89
Clinical Trial Overview of Albert Einstein College of Medicine of Yeshiva University 89
University of Michigan Comprehensive Cancer Center 90
Clinical Trial Overview of University of Michigan Comprehensive Cancer Center 90
New York University School of Medicine 91
Clinical Trial Overview of New York University School of Medicine 91
Five Key Clinical Profiles 92
 

Appendix 137
Abbreviations 137
Definitions 137
Research Methodology 138
Secondary Research 138
About GlobalData 139
Contact Us 139
Disclaimer 139
Source 140

 
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012* 15
Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 16
Metastatic Breast Cancer Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Metastatic Breast Cancer Therapeutics Clinical Trials, G7 Countries, 2012* 18
Metastatic Breast Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Metastatic Breast Cancer Therapeutics Clinical Trials, E7 Countries, 2012* 20
Metastatic Breast Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Metastatic Breast Cancer Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Metastatic Breast Cancer Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Metastatic Breast Cancer Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 33
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 35
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 37
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 38
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 39
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012* 42
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 44
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 47
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012* 49
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 51
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 53
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 55
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 56
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 57
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012* 58
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2012* 59
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Intas Pharmaceuticals Ltd., 2012* 60
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 61
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 62
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by US Oncology, Inc., 2012* 63
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ARCAGY - GINECO, 2012* 64
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 65
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 66
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Reddy's Laboratories Limited, 2012* 67
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 68
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012* 72
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012* 74
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2012* 75
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012* 76
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Medicine and Dentistry New Jersey, 2012* 77
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by FUDAN University, 2012* 78
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012* 79
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southeastern Medical Oncology Center, 2012* 80
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012* 81
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2012* 82
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2012* 83
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012* 84
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2012* 85
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Southwest Oncology Group, 2012* 86
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012* 87
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2012* 88
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Albert Einstein College of Medicine of Yeshiva University, 2012* 89
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan Comprehensive Cancer Center, 2012* 90
Metastatic Breast Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2012* 91

 
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Metastatic Breast Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Metastatic Breast Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Metastatic Breast Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Metastatic Breast Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012* 15
Metastatic Breast Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 16
Metastatic Breast Cancer Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Metastatic Breast Cancer Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Metastatic Breast Cancer Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Metastatic Breast Cancer Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Metastatic Breast Cancer Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Metastatic Breast Cancer Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 33
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 34
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 36
Metastatic Breast Cancer Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 38
GlobalData Methodology 138